CWVIX
Price
$28.04
Change
+$0.15 (+0.54%)
Updated
Oct 17 closing price
Net Assets
893.25M
REREX
Price
$63.50
Change
-$0.27 (-0.42%)
Updated
Oct 17 closing price
Net Assets
137.72B
Interact to see
Advertisement

CWVIX vs REREX

Header iconCWVIX vs REREX Comparison
Open Charts CWVIX vs REREXBanner chart's image
Calvert International Equity I
Price$28.04
Change+$0.15 (+0.54%)
VolumeN/A
Net Assets893.25M
American Funds EUPAC R4
Price$63.50
Change-$0.27 (-0.42%)
VolumeN/A
Net Assets137.72B
CWVIX vs REREX Comparison Chart in %
View a ticker or compare two or three
VS
CWVIX vs. REREX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWVIX is a Hold and REREX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
REREX has more cash in the bank: 138B vs. CWVIX (893M). CWVIX pays higher dividends than REREX: CWVIX (1.17) vs REREX (0.68). CWVIX was incepted earlier than REREX: CWVIX (27 years) vs REREX (23 years). CWVIX (0.95) is less costly to investors than REREX (0.82). REREX is a more actively managed with annual turnover of: 35.00 vs. CWVIX (23.00). REREX has a lower initial minimum investment than CWVIX: REREX (250) vs CWVIX (1000000). REREX annual gain was more profitable for investors over the last year : 10.93 vs. CWVIX (9.60). CWVIX return over 5 years is better than : 32.37 vs. REREX (13.51).
CWVIXREREXCWVIX / REREX
Total Expense Ratio0.890.82109%
Annual Report Gross Expense Ratio0.950.82116%
Fund Existence27 years23 years-
Gain YTD17.47021.39282%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets893M138B1%
Annual Yield % from dividends1.170.68173%
Returns for 1 year9.6010.9388%
Returns for 3 years52.3848.47108%
Returns for 5 years32.3713.51240%
Returns for 10 years79.5541.59191%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMAAU10.50N/A
N/A
Drugs Made In America Acquisition Corp
NEXT6.10-0.01
-0.16%
NextDecade Corp
MI3.81-0.04
-1.04%
NFT Limited
SYM68.52-3.67
-5.08%
Symbotic
DSGN5.74-0.43
-6.97%
Design Therapeutics